title: From innovation to implementation.
abstract: Requirements for the safety and nutritional adequacy of infant formula are set by legislation and aim for the best possible substitute for human milk with regard to growth, development and biological effects. This is, however, a continuous process and has to be supported by science-driven innovative activities of manufacturers and be confirmed by adequate clinical studies performed according to agreed standards.
authors.affiliation: Federal Institute for Risk Assessment, Berlin, Germany.
authors.forename: Hildegard
authors.initials: H
authors.lastname: Przyrembel
authors.forename: Jean Michel
authors.initials: JM
authors.lastname: Antoine
authors.forename: O
authors.initials: O
authors.lastname: Hernell
authors.forename: D
authors.initials: D
authors.lastname: Turck
authors.forename: E
authors.initials: E
authors.lastname: Underwood
authors.forename: M C
authors.initials: MC
authors.lastname: Secretin
mesh_terms: D003257:Consumer Product Safety; D006801:Humans; D007223:Infant; D041943:Infant Formula / Q000737:chemistry / Q000592:standards*; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D008895:Milk, Human / Q000737:chemistry